Abstract

Paracrine effects of mesenchymal stem cells (MSCs) have been suggested play an important role in the treatment of ischemic diseases. Dental pulp Stem cells (DPSCs) share many properties with MSCs. However, the beneficial effects of DPSCs on ischemic diseases remain to be elucidated. The present study, we found that DPSCs secreted higher levels angiogenic factors of VEGF, SDF-1, MCP-1 and PDGF-BB compared with AD-MSCs. We then investigated whether DP-CM can induce the migration of vascular smooth muscle cells (VSMCs) and human umbilical venous endothelial cells (HUVECs) in vitro. Under hypoxia, the apoptosis of HUVECs was inhibited while survival was improved by treatment of DP-CM. In a H2O2-induced cell death assay, DP-CM also significantly reduced HUVECs oxidative stress compare to control group. The tube formation assay demonstrated that the DP-CM group had a greater angiogenic potential than control medium. Results in the mouse model showed both the laser Doppler perfusion index and the relative number of CD31 positive microvessels to be significantly higher in the DP-CM group than in the control group [(77%±11%) vs. (45%±6%), and (6.2±1.1)/HPF vs. (2.3±0.3)/HPF]. In this way, the use of DP-CM may be a suitable means of treating ischemic diseases.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.